Showing results (1-10 of 115) with videos related to
Sort By:
Pageof 12
Cancer Research|June 7, 2013
From integrative genomics to therapeutic targetsRachael Natrajan, Paul WilkersonEndocrine-Related Cancer|June 1, 2018
Splicing dysregulation as a driver of breast cancerAbigail Read, Rachael NatrajanMethods in Molecular Biology (Clifton, N.J.)|July 22, 2017
Identification and Validation of Driver Kinases from Next-Generation Sequencing DataAndri Leonidou, Barrie Peck, Rachael NatrajanThe Journal of Pathology|August 16, 2023
Implications of tumour heterogeneity on cancer evolution and therapy resistance: lessons from breast cancerShefali Thakur, Syed Haider, Rachael NatrajanExpert Review of Molecular Diagnostics|May 7, 2011
Next-generation sequencing applied to molecular diagnosticsRachael Natrajan, Jorge S Reis-FilhoThe Journal of Pathology|June 1, 2022
Definitive study shows no association between ARID1A mutation status and clinical outcome in endometriosis-related ovarian cancers<sup>‡</sup>Saira Khalique, Sarah Nash, Rachael NatrajanCancer Discovery|March 4, 2018
Driver Oncogenes but Not as We Know Them: Targetable Fusion Genes in Breast CancerRachael Natrajan, Andrew N J Tutt, Christopher J LordSeminars in Cancer Biology|November 8, 2019
Translational genomics of ovarian clear cell carcinomaSaira Khalique, Christopher J Lord, Susana Banerjee, et al.NPJ Breast Cancer|December 22, 2021
Subclonal heterogeneity and evolution in breast cancerIoanna Mavrommati, Flora Johnson, Gloria V Echeverria, et al.Human Pathology|July 21, 2007
Chromogenic and fluorescent in situ hybridization in breast cancerMaryou B K Lambros, Rachael Natrajan, Jorge S Reis-FilhoPageof 12